|
|
 |
|
Viewing report
|
|
|
|
Leachables and Extractables - 2009 Conference Proceedings
Smithers Information Ltd, May 2009
Leachables and Extractables have been considered by the pharmaceutical industry for a number of years, illustrated by the FDA requiring NDAs and ANDAs to demonstrate that they had been considered in relation to closure systems. However, up until recently, a majority of the testing and research on this subject focused on Orally Inhaled and Nasal Drug Products (OINDP) as these have the highest risk of leachables and extractables. It is only now that the significance of them on all drug products is being realised and this conference will consider the impact of drug impurities from manufacturing and packaging on all drug products and medical devices.
With ever-evolving best practice and guidelines on leachables & extractables, this conference was a one-stop source of current information on the topic. With two presentations from regulatory authorities, the current regulatory climate will be investigated, and then the impact of this on both the supplier and pharmaceutical perspective explored through expert delivered papers. Other sessions on leachables and extractables in OINDP, Parenteral and Opthlamic Drug Products (PODP), medical devices, dermal membrane, leachables and extractables testing, case studies and polymer producers perspective.
All technical papers presented at the Leachables and Extractables Conference in Barcelona, Spain on 13-14 May 2009 are included in the Proceedings.
Also available
Leachables and Extractables 2008
Customers who bought this item also bought
Leachables and Extractables Handbook: Safety Evaluation, Qualification, and Best Practices Applied to Inhalation Drug Products
Compatibility of Pharmaceutical Solutions and Contact Materials: Safety Assessments of Extractables and Leachables for Pharmaceutical Products
Maven Semantic Healthcare Database (SME Package)
Pediatric Drug Delivery
Personalized Medicine - Scientific and Commercial Aspects
Inhaled Drug Delivery: Devices, Indications, Therapeutics, Markets and Forecasts
Impact of Counterfeits on Pharmaceutical Industry - Counterfeiting Poses Threats to Patient Safety and Revenues of Pharmaceutical Companies
Direct-To-Consumer (DTC) Advertising in Pharmaceuticals - Global Strategic Business Report
Pharmaceuticals Report Bundle
Pediatric Drug Delivery: Technology and Product Opportunities, 2nd Edition
|
|
|
|
